SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-23-043322
Filing Date
2023-04-10
Accepted
2023-04-10 08:05:50
Documents
2
Group Members
MICHAEL TOROK

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2312155d1_sc13g.htm SC 13G 52923
2 EXHIBIT 99.1 tm2312155d1_ex99-1.htm EX-99.1 3615
  Complete submission text file 0001104659-23-043322.txt   58121
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89959 | Film No.: 23809732
SIC: 2834 Pharmaceutical Preparations

Mailing Address 68 MAZZEO DRIVE RANDOLPH MA 02368
Business Address 68 MAZZEO DRIVE RANDOLPH MA 02368 617-680-6709
JEC II Associates, LLC (Filed by) CIK: 0001477326 (see all company filings)

IRS No.: 262258828 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G